Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 7/2021

01-07-2021 | Bisphosphonate | Correction

Correction to: Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review

Authors: Raiza Querrer, Nathália Ferrare, Nilce Melo, Cristine Miron Stefani, Paula Elaine Diniz dos Reis, Carla Ruffeil Moreira Mesquita, Gabriel Alvares Borges, André Ferreira Leite, Paulo Tadeu Figueiredo

Published in: Supportive Care in Cancer | Issue 7/2021

Login to get access

Excerpt

Correction to: Supportive Care in Cancer. …
Metadata
Title
Correction to: Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review
Authors
Raiza Querrer
Nathália Ferrare
Nilce Melo
Cristine Miron Stefani
Paula Elaine Diniz dos Reis
Carla Ruffeil Moreira Mesquita
Gabriel Alvares Borges
André Ferreira Leite
Paulo Tadeu Figueiredo
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06129-5

Other articles of this Issue 7/2021

Supportive Care in Cancer 7/2021 Go to the issue

Original Article

Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practices

Original Article

Oncologist conceptualizations of pediatric palliative care: challenges and definitions

Original Article

How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial

Original Article

Is neuroticism relevant for old cancer survivors? A controlled, population-based study (the Norwegian HUNT-3 survey)

Original Article

Prospective practice survey of management of cetuximab-related skin reactions

Original Article

Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits